These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15532186)

  • 1. [The Swiss HIV Cohort Study--resource for epidemiology and public health].
    Zwahlen M; Gebhardt M; Rickenbach M; Egger M
    Ther Umsch; 2004 Oct; 61(10):593-8. PubMed ID: 15532186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000.
    Sudre P; Rickenbach M; Taffé P; Janin P; Volkart AC; Francioli P;
    Schweiz Med Wochenschr; 2000 Oct; 130(41):1493-500. PubMed ID: 11075414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
    Young J; De Geest S; Spirig R; Flepp M; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Telenti A; Vernazza P; Battegay M; Bucher HC;
    BMJ; 2004 Jan; 328(7430):15. PubMed ID: 14703538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
    Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of integrating food supplementation, nutritional education and HAART (Highly Active Antiretroviral Therapy) on the nutritional status of patients living with HIV/AIDS in Mozambique: results from the DREAM Programme.
    Scarcella P; Buonomo E; Zimba I; Doro Altan AM; Germano P; Palombi L; Marazzi MC
    Ig Sanita Pubbl; 2011; 67(1):41-52. PubMed ID: 21468153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Swiss HIV Cohort Study--a link between clinical research and medical practice].
    Opravil M; Rickenbach M; Ledergerber B
    Ther Umsch; 1998 May; 55(5):329-34. PubMed ID: 9643131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections.
    Ambrosioni J; Junier T; Delhumeau C; Calmy A; Hirschel B; Zdobnov E; Kaiser L; Yerly S;
    AIDS; 2012 Oct; 26(16):2079-86. PubMed ID: 23052354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
    Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
    HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiological surveillance of infection by the human immunodeficiency virus (HIV) and of the acquired immunodeficiency syndrome (AIDS) in French Polynesia in 1991].
    Gras C; Gendron Y; Philippon G; Chungue E; Laudon F; Sirven D; Renaud A; Lebras J; Cardines D; Prigent D
    Med Trop (Mars); 1992; 52(1):51-6. PubMed ID: 1351239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--National HIV Behavioral Surveillance System, 21 U.S. cities, 2010.
    Sionean C; Le BC; Hageman K; Oster AM; Wejnert C; Hess KL; Paz-Bailey G; ;
    MMWR Surveill Summ; 2014 Dec; 63(14):1-39. PubMed ID: 25522191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
    Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
    Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994.
    Commun Dis Rep CDR Rev; 1996 Jan; 6(1):R1-21. PubMed ID: 8581117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Program DREAM (Drug Resource Enhancement against AIDS in Mozambique].
    Assist Inferm Ric; 2003; 22(2):121-6. PubMed ID: 13677167
    [No Abstract]   [Full Text] [Related]  

  • 18. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation and prediction of the HIV-AIDS-epidemic under conditions of HAART using mixtures of incubation time distributions.
    Heisterkamp SH; de Vries R; Sprenger HG; Hubben GA; Postma MJ
    Stat Med; 2008 Mar; 27(6):781-94. PubMed ID: 17597471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Borrell C; Rodríguez-Sanz M; Pasarín MI; Brugal MT; García-de-Olalla P; Marí-Dell'Olmo M; Caylà J
    Eur J Public Health; 2006 Dec; 16(6):601-8. PubMed ID: 16698886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.